vs

Side-by-side financial comparison of Dynatrace, Inc. (DT) and Pennant Group, Inc. (PNTG). Click either name above to swap in a different company.

Dynatrace, Inc. is the larger business by last-quarter revenue ($515.5M vs $289.3M, roughly 1.8× Pennant Group, Inc.). Dynatrace, Inc. runs the higher net margin — 7.8% vs 3.0%, a 4.8% gap on every dollar of revenue. On growth, Pennant Group, Inc. posted the faster year-over-year revenue change (53.2% vs 18.2%). Dynatrace, Inc. produced more free cash flow last quarter ($27.2M vs $17.4M). Over the past eight quarters, Pennant Group, Inc.'s revenue compounded faster (35.8% CAGR vs 16.3%).

Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.

The Pennant Group, Inc. is a U.S.-headquartered healthcare services provider that delivers home health care, hospice services, senior living solutions, and skilled nursing support. It operates across dozens of U.S. states, serving primarily elderly and medically vulnerable populations through its network of localized care facilities.

DT vs PNTG — Head-to-Head

Bigger by revenue
DT
DT
1.8× larger
DT
$515.5M
$289.3M
PNTG
Growing faster (revenue YoY)
PNTG
PNTG
+35.0% gap
PNTG
53.2%
18.2%
DT
Higher net margin
DT
DT
4.8% more per $
DT
7.8%
3.0%
PNTG
More free cash flow
DT
DT
$9.8M more FCF
DT
$27.2M
$17.4M
PNTG
Faster 2-yr revenue CAGR
PNTG
PNTG
Annualised
PNTG
35.8%
16.3%
DT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DT
DT
PNTG
PNTG
Revenue
$515.5M
$289.3M
Net Profit
$40.1M
$8.6M
Gross Margin
81.4%
Operating Margin
14.1%
6.0%
Net Margin
7.8%
3.0%
Revenue YoY
18.2%
53.2%
Net Profit YoY
-88.9%
50.0%
EPS (diluted)
$0.13
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DT
DT
PNTG
PNTG
Q4 25
$515.5M
$289.3M
Q3 25
$493.8M
$229.0M
Q2 25
$477.3M
$219.5M
Q1 25
$445.2M
$209.8M
Q4 24
$436.2M
$188.9M
Q3 24
$418.1M
$180.7M
Q2 24
$399.2M
$168.7M
Q1 24
$380.8M
$156.9M
Net Profit
DT
DT
PNTG
PNTG
Q4 25
$40.1M
$8.6M
Q3 25
$57.2M
$6.1M
Q2 25
$48.0M
$7.1M
Q1 25
$39.3M
$7.8M
Q4 24
$361.8M
$5.8M
Q3 24
$44.0M
$6.2M
Q2 24
$38.6M
$5.7M
Q1 24
$37.9M
$4.9M
Gross Margin
DT
DT
PNTG
PNTG
Q4 25
81.4%
Q3 25
81.8%
Q2 25
82.1%
Q1 25
80.9%
Q4 24
81.1%
Q3 24
81.4%
Q2 24
81.3%
Q1 24
81.1%
Operating Margin
DT
DT
PNTG
PNTG
Q4 25
14.1%
6.0%
Q3 25
14.8%
4.5%
Q2 25
13.1%
5.3%
Q1 25
9.6%
6.0%
Q4 24
10.9%
4.9%
Q3 24
11.2%
6.0%
Q2 24
10.5%
5.7%
Q1 24
6.1%
5.4%
Net Margin
DT
DT
PNTG
PNTG
Q4 25
7.8%
3.0%
Q3 25
11.6%
2.7%
Q2 25
10.0%
3.2%
Q1 25
8.8%
3.7%
Q4 24
82.9%
3.0%
Q3 24
10.5%
3.4%
Q2 24
9.7%
3.4%
Q1 24
10.0%
3.1%
EPS (diluted)
DT
DT
PNTG
PNTG
Q4 25
$0.13
$0.25
Q3 25
$0.19
$0.17
Q2 25
$0.16
$0.20
Q1 25
$0.12
$0.22
Q4 24
$1.19
$0.16
Q3 24
$0.15
$0.20
Q2 24
$0.13
$0.18
Q1 24
$0.13
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DT
DT
PNTG
PNTG
Cash + ST InvestmentsLiquidity on hand
$1.2B
Total DebtLower is stronger
$168.8M
Stockholders' EquityBook value
$2.7B
$374.3M
Total Assets
$4.1B
$968.2M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DT
DT
PNTG
PNTG
Q4 25
$1.2B
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$836.9M
Total Debt
DT
DT
PNTG
PNTG
Q4 25
$168.8M
Q3 25
$26.0M
Q2 25
$37.0M
Q1 25
$52.5M
Q4 24
$0
Q3 24
$108.9M
Q2 24
$82.2M
Q1 24
$83.3M
Stockholders' Equity
DT
DT
PNTG
PNTG
Q4 25
$2.7B
$374.3M
Q3 25
$2.8B
$343.0M
Q2 25
$2.7B
$333.6M
Q1 25
$2.6B
$323.0M
Q4 24
$2.6B
$312.0M
Q3 24
$2.1B
$187.3M
Q2 24
$2.1B
$173.0M
Q1 24
$2.0B
$164.2M
Total Assets
DT
DT
PNTG
PNTG
Q4 25
$4.1B
$968.2M
Q3 25
$4.1B
$753.6M
Q2 25
$4.1B
$751.4M
Q1 25
$4.1B
$743.6M
Q4 24
$3.7B
$679.5M
Q3 24
$3.3B
$646.8M
Q2 24
$3.3B
$602.5M
Q1 24
$3.4B
$578.2M
Debt / Equity
DT
DT
PNTG
PNTG
Q4 25
0.45×
Q3 25
0.08×
Q2 25
0.11×
Q1 25
0.16×
Q4 24
0.00×
Q3 24
0.58×
Q2 24
0.48×
Q1 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DT
DT
PNTG
PNTG
Operating Cash FlowLast quarter
$33.8M
$21.0M
Free Cash FlowOCF − Capex
$27.2M
$17.4M
FCF MarginFCF / Revenue
5.3%
6.0%
Capex IntensityCapex / Revenue
1.3%
1.2%
Cash ConversionOCF / Net Profit
0.84×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$465.5M
$36.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DT
DT
PNTG
PNTG
Q4 25
$33.8M
$21.0M
Q3 25
$32.0M
$13.9M
Q2 25
$269.7M
$34.6M
Q1 25
$162.8M
$-21.2M
Q4 24
$42.2M
$20.6M
Q3 24
$23.6M
$7.7M
Q2 24
$230.7M
$10.5M
Q1 24
$131.7M
$545.0K
Free Cash Flow
DT
DT
PNTG
PNTG
Q4 25
$27.2M
$17.4M
Q3 25
$27.8M
$10.5M
Q2 25
$262.2M
$31.6M
Q1 25
$148.2M
$-23.2M
Q4 24
$37.6M
$17.2M
Q3 24
$20.1M
$6.8M
Q2 24
$227.4M
$8.9M
Q1 24
$121.9M
$-2.6M
FCF Margin
DT
DT
PNTG
PNTG
Q4 25
5.3%
6.0%
Q3 25
5.6%
4.6%
Q2 25
54.9%
14.4%
Q1 25
33.3%
-11.1%
Q4 24
8.6%
9.1%
Q3 24
4.8%
3.8%
Q2 24
57.0%
5.3%
Q1 24
32.0%
-1.7%
Capex Intensity
DT
DT
PNTG
PNTG
Q4 25
1.3%
1.2%
Q3 25
0.8%
1.5%
Q2 25
1.6%
1.4%
Q1 25
3.3%
0.9%
Q4 24
1.1%
1.8%
Q3 24
0.8%
0.5%
Q2 24
0.8%
1.0%
Q1 24
2.6%
2.0%
Cash Conversion
DT
DT
PNTG
PNTG
Q4 25
0.84×
2.43×
Q3 25
0.56×
2.29×
Q2 25
5.62×
4.89×
Q1 25
4.14×
-2.73×
Q4 24
0.12×
3.57×
Q3 24
0.54×
1.24×
Q2 24
5.97×
1.84×
Q1 24
3.47×
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DT
DT

Subscription And Circulation$493.4M96%
Services$22.1M4%

PNTG
PNTG

Home Health Subsegment$136.2M47%
Hospice Subsegment$97.1M34%
Private And Other$36.4M13%
Medicare And Medicaid$19.6M7%
Affiliated Entity$2.2M1%

Related Comparisons